Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Metrics to compare | ENDV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENDVPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −3.1x | −0.5x | |
PEG Ratio | 0.00 | −0.06 | 0.00 | |
Price/Book | 0.0x | 2.2x | 2.6x | |
Price / LTM Sales | 0.0x | 9.5x | 3.3x | |
Upside (Analyst Target) | 0.0% | 219.3% | 43.3% | |
Fair Value Upside | Unlock | 1.6% | 6.9% | Unlock |